Sort   by:  
 Page size 
UnknownPrognostic factors for predicting outcomes after intramedullary nailing of the tibia.
Not available
S-EPMC3448300 | biostudies-literature
UnknownNeuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.
Not available
S-EPMC12015082 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594 | biostudies-literature
UnknownPhase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
Not available
S-EPMC5705229 | biostudies-literature
UnknownSimvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839 | biostudies-literature
UnknownBiological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study.
Not available
S-EPMC8728408 | biostudies-literature
UnknownAlzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Not available
S-EPMC4751673 | biostudies-literature
UnknownMetformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC12261116 | biostudies-literature
UnknownTime to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631 | biostudies-literature
UnknownHigher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC10656670 | biostudies-literature
Sort   by:  
 Page size